EZH2 and cancer: EZH2 can catalyze H3K27me3 dependent on PRC2 for transcriptional silencing, methylate non-histone protein substrates for transcriptional silencing or activation, and act as a PRC2-independent co-activator in transcriptional activation, which has been well documented to overexpress in numerous cancers to regulate cell proliferation 35-39.